Skip to Content


In the US, Naglazyme (galsulfase systemic) is a member of the drug class lysosomal enzymes and is used to treat Mucopolysaccharidosis Type VI.

US matches:

Ingredient matches for Naglazyme


Galsulfase is reported as an ingredient of Naglazyme in the following countries:

  • Belgium
  • Croatia (Hrvatska)
  • Czech Republic
  • Denmark
  • Germany
  • Italy
  • Japan
  • Lithuania
  • Mexico
  • Netherlands
  • Slovakia
  • Spain
  • Sweden
  • Switzerland
  • Taiwan

International Drug Name Search

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.